(CercleFinance.com) – While Eli Lilly developed Mounjaro and Zepbound in order to meet the needs of people affected by diabetes and obesity, the laboratory indicates that it is aware of the misuse of its products, particularly for aesthetic purposes. to lose weight.
The laboratory recalls that Mounjaro and Zepbound are indicated for the treatment of serious illnesses; They are not approved for – and should not be used for – cosmetic weight loss.
Therefore, Eli Lilly does not promote or encourage the use of Mounjaro, Zepbound or any other Lilly drug outside of the FDA-approved indication.
The laboratory also reminds that Mounjaro and Zepbound should only be used on the prescription of an approved healthcare professional.
Copyright © 2024 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends using the buttons below.
